CorMedix Inc. (CRMD) stock
CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.67−0.15 (-3.11%)
Close on Nov 17, 2026Market cap $364.00MP/E –Yield –
CorMedix cash
Cash and short-term investments held at the end of each period.
CorMedix's cash was $256.69M at Jun 30, 2026. For fiscal 2025 it was $148.53M, up 186.8% from the year before. Over ten years it grew 15.4% a year on average. The highest annual figure on record is $148.53M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $148.53M | +186.8% |
| FY2024 | Dec 31, 2024 | $51.79M | -32.0% |
| FY2023 | Dec 31, 2023 | $76.21M | +29.1% |
| FY2022 | Dec 31, 2022 | $59.02M | -10.2% |
| FY2021 | Dec 31, 2021 | $65.70M | +41.2% |
| FY2020 | Dec 31, 2020 | $46.54M | +63.2% |
| FY2019 | Dec 31, 2019 | $28.51M | +60.2% |
| FY2018 | Dec 31, 2018 | $17.80M | +46.4% |
| FY2017 | Dec 31, 2017 | $12.16M | -40.2% |
| FY2016 | Dec 31, 2016 | $20.34M | -42.5% |
| FY2015 | Dec 31, 2015 | $35.39M | +715.4% |
| FY2014 | Dec 31, 2014 | $4.34M | +82.8% |
| FY2013 | Dec 31, 2013 | $2.37M | +184.1% |
| FY2012 | Dec 31, 2012 | $835.47K | -57.9% |
| FY2011 | Dec 31, 2011 | $1.99M | -76.0% |
| FY2010 | Dec 31, 2010 | $8.28M | +450.3% |
| FY2009 | Dec 31, 2009 | $1.51M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $256.69M | +34.6% |
| Q1 FY2026 | Mar 31, 2026 | $178.09M | +129.8% |
| Q4 FY2025 | Dec 31, 2025 | $148.53M | +186.8% |
| Q3 FY2025 | Sep 30, 2025 | $55.72M | +21.0% |
| Q2 FY2025 | Jun 30, 2025 | $190.71M | +318.1% |
| Q1 FY2025 | Mar 31, 2025 | $77.50M | +32.4% |
| Q4 FY2024 | Dec 31, 2024 | $51.79M | -32.0% |
| Q3 FY2024 | Sep 30, 2024 | $46.03M | -46.8% |
| Q2 FY2024 | Jun 30, 2024 | $45.61M | -13.0% |
| Q1 FY2024 | Mar 31, 2024 | $58.55M | +5.3% |
| Q4 FY2023 | Dec 31, 2023 | $76.21M | +29.1% |
| Q3 FY2023 | Sep 30, 2023 | $86.59M | +46.8% |
| Q2 FY2023 | Jun 30, 2023 | $52.40M | -19.2% |
| Q1 FY2023 | Mar 31, 2023 | $55.60M | -10.2% |
| Q4 FY2022 | Dec 31, 2022 | $59.02M | -10.2% |
| Q3 FY2022 | Sep 30, 2022 | $59.00M | -18.3% |
| Q2 FY2022 | Jun 30, 2022 | $64.85M | -17.4% |
| Q1 FY2022 | Mar 31, 2022 | $61.92M | -23.9% |
| Q4 FY2021 | Dec 31, 2021 | $65.70M | +41.2% |
| Q3 FY2021 | Sep 30, 2021 | $72.21M | +94.0% |
| Q2 FY2021 | Jun 30, 2021 | $78.49M | +247.0% |
| Q1 FY2021 | Mar 31, 2021 | $81.41M | +248.5% |
| Q4 FY2020 | Dec 31, 2020 | $46.54M | +63.2% |
| Q3 FY2020 | Sep 30, 2020 | $37.22M | +14.1% |
| Q2 FY2020 | Jun 30, 2020 | $22.62M | -14.8% |
| Q1 FY2020 | Mar 31, 2020 | $23.36M | -11.4% |
| Q4 FY2019 | Dec 31, 2019 | $28.51M | +60.2% |
| Q3 FY2019 | Sep 30, 2019 | $32.61M | +392.9% |
| Q2 FY2019 | Jun 30, 2019 | $26.56M | +444.9% |
| Q1 FY2019 | Mar 31, 2019 | $26.37M | +216.5% |
| Q4 FY2018 | Dec 31, 2018 | $17.80M | +46.4% |
| Q3 FY2018 | Sep 30, 2018 | $6.62M | -45.7% |
| Q2 FY2018 | Jun 30, 2018 | $4.87M | -74.3% |
| Q1 FY2018 | Mar 31, 2018 | $8.33M | -40.2% |
| Q4 FY2017 | Dec 31, 2017 | $12.16M | -40.2% |
| Q3 FY2017 | Sep 30, 2017 | $12.18M | -54.3% |
| Q2 FY2017 | Jun 30, 2017 | $18.99M | – |
| Q1 FY2017 | Mar 31, 2017 | $13.94M | – |
| Q4 FY2016 | Dec 31, 2016 | $20.34M | – |
| Q3 FY2016 | Sep 30, 2016 | $26.65M | – |
See a number that looks wrong?